9:15 – 9:45 a.m. Surgical Management of IBD Andrea Chao Bafford, M.D. 9:45-10:00 a.m. 10:00 – 10:30 a.m. Break 10:30 – 11:00 a.m. Optimal Management of Moderate to Severe Crohn’s Disease Mark Flasar, M.D., M.S. 11:00-11:30 a.m. James Lewis, M.D., MSCE Senior Scholar, Epidemiology Professor of Medicine Professor of Epidemiology Perelman School of Medicine, University of Pennsylvania David A. Schwartz, M.D. Associate Professor of Medicine Director, Inflammatory Bowel Disease Center Vanderbilt University Medical Center 1:15– 1:45 p.m. Optimal Management of Perianal Crohn’s Disease Leyla Ghazi, M.D. CREDIT STATEMENT The University of Maryland School of Medicine designates this Live activity for a maximum of 6 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 1:45– 2:15 p.m. Mucosal Healing or Clinical Endpoints - Which is Best? Richard MacDermott, M.D. 2:15– 2:45 p.m. Risks of Immune Suppressant and Biologic Therapies in IBD James Lewis, M.D., M.S.C.E. 2:45– 3:15 p.m. Women’s Health Issues in IBD Seema Patil, M.D. 3:15– 3:30 p.m. Q&A 3:30-3:45 p.m. Closing - Raymond Cross, M.D., M.S. FACULTY DISCLOSURE It is the policy of the University of Maryland School of Medicine to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, all persons in a position to control activity content of continuing medical education activities must disclose their financial relationships with commercial interests relevant to the content of the CME activity. Any conflicts of interest identified must be resolved prior to presentation of the educational activity. AMERICANS WITH DISABILITIES ACT If you require special accommodations to attend or participate in this CME activity, please provide information about your requirements to Gloria Owens at 410-706-3956 or (1-800-735-2258 TTY/Voice) at least five business days in advance of the activity. RESERVATION CANCELLATION POLICY If you must cancel, please notify Gloria Owens by phone: 410-706-3956, or fax, 410-706-3103. The University of Maryland School of Medicine reserves the right to cancel or postpone any course due to unforeseen circumstances. In the event of cancellation or postponement, the University of Maryland School of Medicine will refund only the registration and is not responsible for any related hotel accommodations or travel expenses. REGISTRATION FORM Lunch You May Register On-Line at: https://cmetracker.net/UMD (VISA/MC) 12:15– 1:15 p.m. ACCREDITATION The University of Maryland School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. If mailing registration, please complete form and include with check. Q&A Please check appropriate box: 12:00– 12:15 p.m. Name: _____________________________________ Degree:______________ Mailing Address: _________________________________________________ City: ____________________________ State:______ Zip Code:___________ Daytime Phone: ______-______-_________ Fax: ______-______-__________ Specialty: _______________________________________________________ e-mail address: ___________________________________________________ Management of Post-Operative Crohn’s Disease Miguel Regueiro, M.D. (must show ID with affiliation at registration) Richard MacDermott, M.D. Distinguished Chair in Medicine Professor of Medicine Albany Medical College Director of the Inflammatory Bowel Disease Center Albany Medical Center Miguel Riguero, M.D. Professor of Medicine Associate Chief for Education Co-Director, Inflammatory Bowel Disease Center Head, IBD Clinical Program Director, Gastroenterology Fellowship Program University of Pittsburgh Medical Center ■ Physicians $100 ■ CRNP/RN/Dieticians/Nutritionists $50 ■ Other $50 ■ Fellows ■ Residents ■ CRNP ■ RN (UMMC complimentary) ■ Fellows/Residents from an accredited program are complimentary • Understand the risks of immune suppressant and biologic therapy in the treatment of Crohn’s disease and ulcerative colitis Hans Herfarth, M.D., PhD Professor of Medicine University of North Carolina School of Medicine CME Code: MED121109 • Understand unique aspects of treatment in women with inflammatory bowel disease Management of Complicated or Medically Refractory Crohn’s Disease David Schwartz, M.D. VISITING FACULTY 11:30– 12:00 p.m. • Understand how to treat patients with moderate to severe Crohn’s disease and ulcerative colitis • Understand how to treat patients with complicated or medically refractory Crohn’s disease Q&A Seema Patil, M.D. Assistant Professor of Medicine Division of Gastroenterology and Hepatology UPDATE IN INFLAMMATORY BOWEL DISEASE Screening and Surveillance for Dysplasia in Chronic Colitis Raymond Cross, M.D., M.S. Leyla Ghazi, M.D. Assistant Professor of Medicine Division of Gastroenterology & Hepatology Friday, November 9, 2012 8:45 – 9:15 a.m. Mark H. Flasar, M.D., M.S. Course Co-Director Assistant Professor of Medicine Associate Program Director, Inflammatory Bowel Disease Program Division of Gastroenterology and Hepatology Location: Southern Management Corporation Campus Center 621 W. Lombard Street, Baltimore, Maryland 21201. The SMC Campus Center is situated between the Health Science Library and the University of Maryland School of Nursing. Optimal Management of Moderate to Severe Ulcerative Colitis Hans Herfarth, M.D., Ph.D Andrea Chao Bafford, M.D. Assistant Professor of Surgery Department of Surgery Division of General and Oncologic Surgery Registration Fee: Includes instruction materials, meals, CME certificate, and complimentary parking at the Pratt Garage. 8:15-8:45 a.m. Raymond K. Cross, M.D., M.S. Course Co-Director Associate Professor of Medicine Director, Inflammatory Bowel Disease Program Division of Gastroenterology and Hepatology Please make checks payable to: University of Maryland Mail to: Office of Faculty Affairs and Professional Development, Attn: Gloria Owens, 655 W. Baltimore Street, BRB14-012, Baltimore, MD 21201 Further Info: 410.706.3956 At the conclusion of this course, participants should be able to: Welcome and Introduction - Raymond Cross, M.D., M.S. Confirmation will be Mailed upon Paid Registration. Course Objectives 8:00-8:15 a.m. If mailing registration please mail by November 2, 2012 Since IBD is common and there is confusion regarding the optimal use of diagnostic tests, traditional and non-traditional therapeutics, and surgery in patients who are at important transition points in their lives, this one-day symposium highlights the diagnosis and management of patients with these disorders. Registration and Breakfast Driving Directions: I 7:15-8:00 a.m. From the North or South: Follow 195 to exit 52 (Russell Street). Follow Russell as it merges into Paca Street. Turn left onto Lombard St. and cross over Greene St and the campus center will be on the left. UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE FACULTY nflammatory bowel disease (IBD), comprised of ulcerative colitis and Crohn’s disease, affects approximately 1.4 million patients in the United States. Both diseases are chronic, characterized by periodic exacerbations of symptoms, and have a negative impact on quality of life. IBD affects women equally, (usually during childbearing age). As such, IBD providers are often challenged to care for these uniquely complex patients at important transition points in their lives. This care is administered in the face of continually evolving and contro-versial prognostic, diagnostic and therapeutic issues as the field of IBD advances. Given that the majority of Crohn’s disease (CD) patients develop complicated disease (including perianal involvement), IBD providers must also be familiar with medical and surgical management options in this patient subgroup. Furthermore, as a significant proportion of patients will become refractory to therapy at some point in their disease, IBD providers must be able to recognize the complex reasons for treatment refractory disease and be prepared to appropriately escalate medical and surgical care when needed. Patients with chronic colitis are also at risk for development of dysplasia; strategies to detect and treat dysplasia have evolved to include utilization of advanced endoscopic techniques like chromoendoscopy. Together, this makes it challenging for providers to ensure that IBD diagnostics and treatment are consistent with current guidelines and accepted standards. From I-83: Follow 183 (Jones Falls Expressway) until expressway ends. Go two traffic lights and turn right onto Lombard Street. Follow Lombard Street for 13 traffic lights and right after crossing over Greene St., the campus center will be on the left. Agenda Parking: Complimentary parking is available at the Pratt Garage located at 621 W. Lombard Street, Baltimore, Maryland 21201. Please bring your parking voucher to registration for validation. Course Description Faculty Update in Inflammatory Bowel Disease is the 7th University of Maryland School of Medicine Division of Gastroenterology Symposium. This in-depth symposium will focus on treating patients with IBD and is intended for practicing physicians, surgeons, mid level providers, nurses, and nutritionists. The presentations, discussion periods and interactive formats are intended to stimulate audience participation in the discussion of these timely topics. Non Profit Org. U.S. postage PAID Baltimore, MD Permit #7620 Intended Audience Symposium Co-Directors Raymond K. Cross, M.D., M.S. Associate Professor of Medicine and Director of the Inflammatory Bowel Disease Program of the Division of Gastroenterology and Hepatology at the University of Maryland School of Medicine and Co-Director of the Digestive Health Center University of Maryland Medical Center. His clinical research interests are focused on the optimization of patient outcomes using telemedicine systems, disparities in care of patients with inflammatory bowel disease, and in the design and implementation of clinical trials. He is a physician member of the Crohn's and Colitis Foundation and is Chairman of the National Patient Education Committee of the Crohn’s and Colitis Foundation of America. Mark H. Flasar, M.D., M.S. Assistant Professor of Medicine, Associate Director of the Inflammatory Bowel Disease Program and Director of the Gastroenterology and Hepatology Fellowship Program of the Division of Gastroenterology and Hepatology at the University of Maryland School of Medicine. His clinical research interests focus on disparities in care of patients with inflammatory bowel disease, outcomes of medical therapies, and the design and implementation of clinical trials. He is a physician member of the Crohn’s and Colitis Foundation of America and is a member of the Mission Committee of the Maryland and Southern Delaware Chapter of the Crohn’s and Colitis Foundation of America. Faculty Invites You to Attend The faculty for this CME accredited symposium represents a combination of distinguished clinician investigators in the Division of Gastroenterology and Hepatology as well as the Division of General Surgery at the University of Maryland School of Medicine. Experts of reknown from other medical schools include the Albany Medical College, University of Pittsburgh Medical Center, University of North Carolina School of Medicine – Chapel Hill, Perelman School of Medicine, University of Pennsylvania and Vanderbilt University. Update in Inflammatory Bowel Disease For more on what’s happening in and around Baltimore, please visit www.baltimore.org Friday, November 9, 2012 Marriott Inner Harbor Hotel – Rate $145 per night (plus city/state tax) 110 South Eutaw Street, Baltimore, Maryland 21201, Ph. # 410-962-0202 **When reserving, please mention the University of Maryland Rate. Room availability is dependent upon the Marriott Inner Harbor Hotel. To reserve a room on-line: Baltimore Marriott Inner Harbor at Camden Yards >>. The Marriott Inner Harbor Hotel is within walking distance to the Babe Ruth Museum, Oriole Park, Sports Legends Museum; as well as Baltimore’s famous Inner Harbor, the Hippodrome Theater, fashionable shopping, and world-class dining. Friday, November 9, 2012 Update in Inflammatory Bowel Disease If you plan to stay in Baltimore for the conference, the following hotel is offering the University of Maryland Rate and is in walking distance to the campus center: 655 W. Baltimore Street, Room 14-012, BRB Baltimore, Maryland 21201 Hotel Accommodations University of Maryland Southern Management Corporation Campus Center 621 W. Lombard Street • Baltimore, Maryland 21201 Presented by University of Maryland School of Medicine